Cargando…

Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model

BACKGROUND: The purpose of this study was to evaluate the biodistribution and toxicity of amphotericin B (AmB) following multiple oral administrations of a novel tropically stable lipid-based formulation (iCo-010). METHODS: BALB/c mice were allocated into six groups: oral iCo-010 twice daily for 5 d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivak, Olena, Gershkovich, Pavel, Lin, Molly, Wasan, Ellen K, Zhao, Jinying, Owen, David, Clement, John G, Wasan, Kishor M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162910/ https://www.ncbi.nlm.nih.gov/pubmed/21824435 http://dx.doi.org/10.1186/1476-511X-10-135

Ejemplares similares

Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis
por: Ibrahim, Fady, et al.
Publicado: (2013)

A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model
por: Wasan, Ellen K., et al.
Publicado: (2010)

In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines
por: Leon, Carlos G, et al.
Publicado: (2011)

Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections
por: Wasan, Ellen, et al.
Publicado: (2022)

Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in Apolipoprotein E deficient mice fed a high cholesterol and high fat diet
por: Sivak, Olena, et al.
Publicado: (2009)

The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
por: Cuddihy, Grace, et al.
Publicado: (2019)

Effects of climate change on soil health resulting in an increased global spread of neglected tropical diseases
por: Wasan, John Paul M., et al.
Publicado: (2023)

Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
por: Leon, Carlos G., et al.
Publicado: (2008)

Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome
por: Gershkovich, Pavel, et al.
Publicado: (2015)

Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia
por: Wang, Xia, et al.
Publicado: (2017)

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome(®) and AmBisome(®) in murine cutaneous leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2018)

Analytical Strategies to Analyze the Oxidation Products of Phytosterols, and Formulation-Based Approaches to Reduce Their Generation
por: Gachumi, George, et al.
Publicado: (2021)

An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
por: Mohammed, Munawar A., et al.
Publicado: (2017)

Canadian contributions to research on neglected tropical diseases
por: Gyorkos, Theresa W., et al.
Publicado: (2021)

Drug Delivery Technology Development in Canada
por: Wasan, Kishor M., et al.
Publicado: (2019)

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2017)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

Development and Characterization of Liposomal Formulations Containing Phytosterols Extracted from Canola Oil Deodorizer Distillate along with Tocopherols as Food Additives
por: Poudel, Asmita, et al.
Publicado: (2019)

Which New Approaches to Tackling Neglected Tropical Diseases Show Promise?
por: Spiegel, Jerry M., et al.
Publicado: (2010)

Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
por: Wasan, Ellen K., et al.
Publicado: (2019)

Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape—A Summary of This Indispensable Special Issue
por: Davies, Neal M., et al.
Publicado: (2018)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

LBODP010 A Case of Glucocorticoid Resistance Syndrome
por: Sudhakar, Shwetha Mallesara, et al.
Publicado: (2022)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication
por: Anderson, Nathan, et al.
Publicado: (2020)

P010 Abstract Withdrawn
Publicado: (2021)

Nephrotoxicity of three formulations of amphotericin B: trial sequential analysis
por: Caputo, Rosaria, et al.
Publicado: (2020)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma
por: Henderson, Ryan J, et al.
Publicado: (2009)

The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells
por: Sachs-Barrable, Kristina, et al.
Publicado: (2014)

Effect of simvastatin on castration-resistant prostate cancer cells
por: Kim, Jenny Hanbi, et al.
Publicado: (2014)

Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials
por: Akbar, Noor, et al.
Publicado: (2022)

Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox
por: Peruzzu, Daniela, et al.
Publicado: (2023)

DICE Manual Version 0.10
por: Dell'Acqua, A
Publicado: (1995)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin
por: Wang, Tiechuang, et al.
Publicado: (2012)

Size-Dependent Biodistribution of Fluorescent Furano-Allocolchicinoid-Chitosan Formulations in Mice
por: Gracheva, Iuliia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_arnu0fq6d5ceavrc8i6ov8e2m9